Atividade antimicrobiana do Pg-AMP1 recombinante, um peptídeo rico em glicina, isolado de goiaba (Psidium guajava L.)

Abstract

The search for new antibiotics of broad spectrum of activity has increased in recent decades due to the increasing number of bacteria resistant to conventional antibiotics. The Pg-AMP1 recombinant peptide expressed in a heterologous system in Escherichia coli, strains showed antibacterial activity against Gram-positive and Gram-negative. From the sequence of amino acid peptide isolated from the seeds of guava (Psidium guajava L.) peptide corresponding to the gene was modified using the preferred codon for expression in E. coli and constructed a vector for expression. A region coding for the histidine tail was merged the gene-pg amp1 allowing purification by affinity chromatography with nickel ions immobilized on the column sepharose. Using SDS-PAGE and in silico analysis identified the molecular weight of Pg-AMP1 recombinant with 7.368 kDa and pI 8.93. The recombinant peptide was expressed mostly as insoluble form, adding up in inclusion bodies, which were treated with denaturants agents to solubilize the peptide. The purification of peptide by nickel sepharose column yielded 13 mg per liter of culture medium. The Pg-AMP1 recombinant peptide showed activity against Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa and against gram-positive Staphylococcus aureus and Staphylococcus epidermidis. The recombinant peptide Pg-AMP1 showed no activity against the phytopathogenic fungi tested. Due to its action against these strains of human pathogenic bacteria, the recombinant Pg-AMP1 is a promising antimicrobial for use in developing new antibiotics against strains resistant to commonly used drugs.